Sectoral Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,120	Closed	-$218K	–	134
2018 Q3	$218K	Buy	+10,120	New	+$235K	0.02%	130
2017 Q3	–	Sell	-602,279	Closed	-$20M	–	66
2017 Q2	$20M	Sell	602,279 -151,542	-20%	-$4.69M	2.19%	19
2017 Q1	$24.2M	Buy	+753,821	New	+$25.7M	2.83%	15
2016 Q4	–	Sell	-454,172	Closed	-$20.9M	–	61
2016 Q3	$20.9M	Sell	454,172 -161,763	-26%	-$8.44M	2.05%	21
2016 Q2	$30.9M	Buy	615,935 +106,825	+21%	+$5.69M	3.19%	13
2016 Q1	$27.2M	Sell	509,110 -96,812	-16%	-$5.68M	1.32%	25
2015 Q4	$39.8M	Buy	605,922 +10,972	+2%	+$678K	1.7%	18
2015 Q3	$33.6M	Buy	594,950 +235,118	+65%	+$15.2M	1.54%	20
2015 Q2	$21.3M	Sell	359,832 -1,300,751	-78%	-$80.2M	0.89%	35
2015 Q1	$103M	Buy	1,660,583 +279,695	+20%	+$16.3M	3.93%	8
2014 Q4	$79.4M	Sell	1,380,888 -327,303	-19%	-$18.2M	3.56%	7
2014 Q3	$91.8M	Buy	1,708,191 +195,604	+13%	+$10.4M	3.86%	7
2014 Q2	$79.3M	Buy	1,512,587 +70,595	+5%	+$3.61M	3.36%	7
2014 Q1	$76.2M	Buy	1,441,992 +828,343	+135%	+$38.3M	3.13%	9
2013 Q4	$24.6M	Buy	613,649 +179,600	+41%	+$7.07M	1.06%	35
2013 Q3	$16.4M	Buy	434,049 +26,300	+6%	+$1.03M	0.79%	39
2013 Q2	$16M	Buy	+407,749	New	+$15.9M	0.47%	42